Triple-negative breast cancer (TNBC), defined by the absence of estrogen receptor, progesterone receptor, and overexpression of human epidermal growth factor receptor 2 gene (HR−/HER2−), is a particularly aggressive subtype of breast cancer. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.